Reevaluating hybrid neurofibroma/schwannoma: Predominance of schwannoma features despite CD34 positivity and initial neurofibroma diagnosis

Schwannomas consist of both high‐cellularity regions (Antoni A area) and hypocellular regions (Antoni B area) in histopathological findings. Neurofibromas characteristically consist of CD34 positive spindle cells with thin, wavy, nuclei and wavy collagen bands. Previous reports have described segmen...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of dermatology 2024-11, Vol.51 (11), p.1461-1469
Hauptverfasser: Katsumi, Tatsuya, Hayashi, Ryota, Takei, Shingo, Ansai, Osamu, Takatsuka, Sumiko, Takenouchi, Tatsuya, Saito, Kyota, Suda, Kazuaki, Yoshihara, Kosuke, Nagai, Takahiro, Okuda, Shujiro, Fukumoto, Takaya, Ansai, Shin‐ichi, Nakamura, Anna, Katsuumi, Koji, Ariizumi, Takashi, Ogose, Akira, Kawashima, Hiroyuki, Abe, Riichiro
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1469
container_issue 11
container_start_page 1461
container_title Journal of dermatology
container_volume 51
creator Katsumi, Tatsuya
Hayashi, Ryota
Takei, Shingo
Ansai, Osamu
Takatsuka, Sumiko
Takenouchi, Tatsuya
Saito, Kyota
Suda, Kazuaki
Yoshihara, Kosuke
Nagai, Takahiro
Okuda, Shujiro
Fukumoto, Takaya
Ansai, Shin‐ichi
Nakamura, Anna
Katsuumi, Koji
Ariizumi, Takashi
Ogose, Akira
Kawashima, Hiroyuki
Abe, Riichiro
description Schwannomas consist of both high‐cellularity regions (Antoni A area) and hypocellular regions (Antoni B area) in histopathological findings. Neurofibromas characteristically consist of CD34 positive spindle cells with thin, wavy, nuclei and wavy collagen bands. Previous reports have described segments of schwannomas with neurofibroma features as hybrid tumors, although hybrid tumors were diagnosed based on partial CD34 positivity in many previous reports. On the other hand, the Antoni B area of some schwannomas was reported to be positive for CD34. Therefore, the definition of a hybrid tumor has not been clear. The objective of this study was to determine whether only CD34 positive findings in schwannomas could be used to define a hybrid tumor. In the analysis of our patient with schwannomatosis caused by a novel LZTR1 germline mutation, part of the tumor had CD34 positive hypocellular regions. These regions contained no thin, wavy, nuclei, indicating an Antoni B area. Laser microdissection was used to investigate the genetic background and differences in molecular mechanisms between CD34 positive and CD34 negative regions. All mutations identified in CD34 positive regions were also found in CD34 negative regions. Our data could not clear the genetic background of Antoni B which was CD34 positive area. We then reviewed the pathologies of 66 sporadic schwannomas. Histopathological examinations of all schwannomas revealed the absence of thin, wavy, nuclei and wavy collagen bands, and no hybrid tumors were found in any of the cases. Ten of 66 patients were randomly selected for CD34 immunostaining and positivity was found in all cases. Our data suggest that it is difficult to distinguish schwannomas by staining for CD34 alone, as Antoni B areas can also be positive for CD34. Therefore, CD34 staining alone should not be used to diagnose hybrid tumors in patients with schwannomas.
doi_str_mv 10.1111/1346-8138.17343
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3123549077</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3123165988</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2553-a9e7b4c2096472476bea8ddad76be3cb19e7d5d96ef2a3bce7a19529e75a37b73</originalsourceid><addsrcrecordid>eNqFkU1v1DAQhi0EokvhzA1Z4tJLuv6I44Qb2pYvVQKh9mxN4knrKrEXO2m1v4E_jdMtRfRSXzyeefza0kPIW86OeV5rLsuqqLmsj7mWpXxGVg-d52TFZK0KUTJ9QF6ldM2YaBRnL8mBbMpaq0qsyO-fiDcwzDA5f0mvdm10lnqcY-hdG8MI69Rd3YL3ufxAf0S0YXQefIc09PTfjPYI0xwxUYtp6yakmxNZ0m1IbnI3btpR8JY6n08w_PcAtQ4ufebSa_KihyHhm_v9kFx8Oj3ffCnOvn_-uvl4VnRCKVlAg7otO8GaqtSi1FWLUFsLdqlk1_I8t8o2FfYCZNuhBt4okbsKpG61PCRH-9xtDL9mTJMZXepwGMBjmJORXEhVNkwv6PtH6HWYo8-_u6N4pZq6ztR6T3UxpBSxN9voRog7w5lZPJnFilmsmDtP-ca7-9y5HdE-8H_FZEDtgVs34O6pPPPt5HQf_AfYTp_Z</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3123165988</pqid></control><display><type>article</type><title>Reevaluating hybrid neurofibroma/schwannoma: Predominance of schwannoma features despite CD34 positivity and initial neurofibroma diagnosis</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><creator>Katsumi, Tatsuya ; Hayashi, Ryota ; Takei, Shingo ; Ansai, Osamu ; Takatsuka, Sumiko ; Takenouchi, Tatsuya ; Saito, Kyota ; Suda, Kazuaki ; Yoshihara, Kosuke ; Nagai, Takahiro ; Okuda, Shujiro ; Fukumoto, Takaya ; Ansai, Shin‐ichi ; Nakamura, Anna ; Katsuumi, Koji ; Ariizumi, Takashi ; Ogose, Akira ; Kawashima, Hiroyuki ; Abe, Riichiro</creator><creatorcontrib>Katsumi, Tatsuya ; Hayashi, Ryota ; Takei, Shingo ; Ansai, Osamu ; Takatsuka, Sumiko ; Takenouchi, Tatsuya ; Saito, Kyota ; Suda, Kazuaki ; Yoshihara, Kosuke ; Nagai, Takahiro ; Okuda, Shujiro ; Fukumoto, Takaya ; Ansai, Shin‐ichi ; Nakamura, Anna ; Katsuumi, Koji ; Ariizumi, Takashi ; Ogose, Akira ; Kawashima, Hiroyuki ; Abe, Riichiro</creatorcontrib><description>Schwannomas consist of both high‐cellularity regions (Antoni A area) and hypocellular regions (Antoni B area) in histopathological findings. Neurofibromas characteristically consist of CD34 positive spindle cells with thin, wavy, nuclei and wavy collagen bands. Previous reports have described segments of schwannomas with neurofibroma features as hybrid tumors, although hybrid tumors were diagnosed based on partial CD34 positivity in many previous reports. On the other hand, the Antoni B area of some schwannomas was reported to be positive for CD34. Therefore, the definition of a hybrid tumor has not been clear. The objective of this study was to determine whether only CD34 positive findings in schwannomas could be used to define a hybrid tumor. In the analysis of our patient with schwannomatosis caused by a novel LZTR1 germline mutation, part of the tumor had CD34 positive hypocellular regions. These regions contained no thin, wavy, nuclei, indicating an Antoni B area. Laser microdissection was used to investigate the genetic background and differences in molecular mechanisms between CD34 positive and CD34 negative regions. All mutations identified in CD34 positive regions were also found in CD34 negative regions. Our data could not clear the genetic background of Antoni B which was CD34 positive area. We then reviewed the pathologies of 66 sporadic schwannomas. Histopathological examinations of all schwannomas revealed the absence of thin, wavy, nuclei and wavy collagen bands, and no hybrid tumors were found in any of the cases. Ten of 66 patients were randomly selected for CD34 immunostaining and positivity was found in all cases. Our data suggest that it is difficult to distinguish schwannomas by staining for CD34 alone, as Antoni B areas can also be positive for CD34. Therefore, CD34 staining alone should not be used to diagnose hybrid tumors in patients with schwannomas.</description><identifier>ISSN: 0385-2407</identifier><identifier>ISSN: 1346-8138</identifier><identifier>EISSN: 1346-8138</identifier><identifier>DOI: 10.1111/1346-8138.17343</identifier><identifier>PMID: 39487562</identifier><language>eng</language><publisher>England: Wiley Subscription Services, Inc</publisher><subject>Adult ; Antigens, CD34 - analysis ; Antigens, CD34 - metabolism ; CD34 ; CD34 antigen ; Collagen ; Female ; Humans ; hybrid schwannoma/neurofibroma ; LZTR1 ; Male ; Middle Aged ; Molecular modelling ; Mutation ; Neurilemmoma - diagnosis ; Neurilemmoma - pathology ; Neurofibroma - diagnosis ; Neurofibroma - metabolism ; Neurofibroma - pathology ; Neurofibromatoses ; Schwann cells ; schwannomatosis ; Skin Neoplasms - diagnosis ; Skin Neoplasms - metabolism ; Skin Neoplasms - pathology ; Tumors</subject><ispartof>Journal of dermatology, 2024-11, Vol.51 (11), p.1461-1469</ispartof><rights>2024 Japanese Dermatological Association.</rights><rights>Copyright © 2024 Japanese Dermatological Association</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c2553-a9e7b4c2096472476bea8ddad76be3cb19e7d5d96ef2a3bce7a19529e75a37b73</cites><orcidid>0000-0002-7582-8609 ; 0000-0001-6998-531X ; 0000-0001-9944-2228 ; 0000-0002-6818-944X ; 0000-0002-0373-5833 ; 0000-0001-7036-7084</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2F1346-8138.17343$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2F1346-8138.17343$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>315,781,785,1418,27928,27929,45578,45579</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39487562$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Katsumi, Tatsuya</creatorcontrib><creatorcontrib>Hayashi, Ryota</creatorcontrib><creatorcontrib>Takei, Shingo</creatorcontrib><creatorcontrib>Ansai, Osamu</creatorcontrib><creatorcontrib>Takatsuka, Sumiko</creatorcontrib><creatorcontrib>Takenouchi, Tatsuya</creatorcontrib><creatorcontrib>Saito, Kyota</creatorcontrib><creatorcontrib>Suda, Kazuaki</creatorcontrib><creatorcontrib>Yoshihara, Kosuke</creatorcontrib><creatorcontrib>Nagai, Takahiro</creatorcontrib><creatorcontrib>Okuda, Shujiro</creatorcontrib><creatorcontrib>Fukumoto, Takaya</creatorcontrib><creatorcontrib>Ansai, Shin‐ichi</creatorcontrib><creatorcontrib>Nakamura, Anna</creatorcontrib><creatorcontrib>Katsuumi, Koji</creatorcontrib><creatorcontrib>Ariizumi, Takashi</creatorcontrib><creatorcontrib>Ogose, Akira</creatorcontrib><creatorcontrib>Kawashima, Hiroyuki</creatorcontrib><creatorcontrib>Abe, Riichiro</creatorcontrib><title>Reevaluating hybrid neurofibroma/schwannoma: Predominance of schwannoma features despite CD34 positivity and initial neurofibroma diagnosis</title><title>Journal of dermatology</title><addtitle>J Dermatol</addtitle><description>Schwannomas consist of both high‐cellularity regions (Antoni A area) and hypocellular regions (Antoni B area) in histopathological findings. Neurofibromas characteristically consist of CD34 positive spindle cells with thin, wavy, nuclei and wavy collagen bands. Previous reports have described segments of schwannomas with neurofibroma features as hybrid tumors, although hybrid tumors were diagnosed based on partial CD34 positivity in many previous reports. On the other hand, the Antoni B area of some schwannomas was reported to be positive for CD34. Therefore, the definition of a hybrid tumor has not been clear. The objective of this study was to determine whether only CD34 positive findings in schwannomas could be used to define a hybrid tumor. In the analysis of our patient with schwannomatosis caused by a novel LZTR1 germline mutation, part of the tumor had CD34 positive hypocellular regions. These regions contained no thin, wavy, nuclei, indicating an Antoni B area. Laser microdissection was used to investigate the genetic background and differences in molecular mechanisms between CD34 positive and CD34 negative regions. All mutations identified in CD34 positive regions were also found in CD34 negative regions. Our data could not clear the genetic background of Antoni B which was CD34 positive area. We then reviewed the pathologies of 66 sporadic schwannomas. Histopathological examinations of all schwannomas revealed the absence of thin, wavy, nuclei and wavy collagen bands, and no hybrid tumors were found in any of the cases. Ten of 66 patients were randomly selected for CD34 immunostaining and positivity was found in all cases. Our data suggest that it is difficult to distinguish schwannomas by staining for CD34 alone, as Antoni B areas can also be positive for CD34. Therefore, CD34 staining alone should not be used to diagnose hybrid tumors in patients with schwannomas.</description><subject>Adult</subject><subject>Antigens, CD34 - analysis</subject><subject>Antigens, CD34 - metabolism</subject><subject>CD34</subject><subject>CD34 antigen</subject><subject>Collagen</subject><subject>Female</subject><subject>Humans</subject><subject>hybrid schwannoma/neurofibroma</subject><subject>LZTR1</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Molecular modelling</subject><subject>Mutation</subject><subject>Neurilemmoma - diagnosis</subject><subject>Neurilemmoma - pathology</subject><subject>Neurofibroma - diagnosis</subject><subject>Neurofibroma - metabolism</subject><subject>Neurofibroma - pathology</subject><subject>Neurofibromatoses</subject><subject>Schwann cells</subject><subject>schwannomatosis</subject><subject>Skin Neoplasms - diagnosis</subject><subject>Skin Neoplasms - metabolism</subject><subject>Skin Neoplasms - pathology</subject><subject>Tumors</subject><issn>0385-2407</issn><issn>1346-8138</issn><issn>1346-8138</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU1v1DAQhi0EokvhzA1Z4tJLuv6I44Qb2pYvVQKh9mxN4knrKrEXO2m1v4E_jdMtRfRSXzyeefza0kPIW86OeV5rLsuqqLmsj7mWpXxGVg-d52TFZK0KUTJ9QF6ldM2YaBRnL8mBbMpaq0qsyO-fiDcwzDA5f0mvdm10lnqcY-hdG8MI69Rd3YL3ufxAf0S0YXQefIc09PTfjPYI0xwxUYtp6yakmxNZ0m1IbnI3btpR8JY6n08w_PcAtQ4ufebSa_KihyHhm_v9kFx8Oj3ffCnOvn_-uvl4VnRCKVlAg7otO8GaqtSi1FWLUFsLdqlk1_I8t8o2FfYCZNuhBt4okbsKpG61PCRH-9xtDL9mTJMZXepwGMBjmJORXEhVNkwv6PtH6HWYo8-_u6N4pZq6ztR6T3UxpBSxN9voRog7w5lZPJnFilmsmDtP-ca7-9y5HdE-8H_FZEDtgVs34O6pPPPt5HQf_AfYTp_Z</recordid><startdate>202411</startdate><enddate>202411</enddate><creator>Katsumi, Tatsuya</creator><creator>Hayashi, Ryota</creator><creator>Takei, Shingo</creator><creator>Ansai, Osamu</creator><creator>Takatsuka, Sumiko</creator><creator>Takenouchi, Tatsuya</creator><creator>Saito, Kyota</creator><creator>Suda, Kazuaki</creator><creator>Yoshihara, Kosuke</creator><creator>Nagai, Takahiro</creator><creator>Okuda, Shujiro</creator><creator>Fukumoto, Takaya</creator><creator>Ansai, Shin‐ichi</creator><creator>Nakamura, Anna</creator><creator>Katsuumi, Koji</creator><creator>Ariizumi, Takashi</creator><creator>Ogose, Akira</creator><creator>Kawashima, Hiroyuki</creator><creator>Abe, Riichiro</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-7582-8609</orcidid><orcidid>https://orcid.org/0000-0001-6998-531X</orcidid><orcidid>https://orcid.org/0000-0001-9944-2228</orcidid><orcidid>https://orcid.org/0000-0002-6818-944X</orcidid><orcidid>https://orcid.org/0000-0002-0373-5833</orcidid><orcidid>https://orcid.org/0000-0001-7036-7084</orcidid></search><sort><creationdate>202411</creationdate><title>Reevaluating hybrid neurofibroma/schwannoma: Predominance of schwannoma features despite CD34 positivity and initial neurofibroma diagnosis</title><author>Katsumi, Tatsuya ; Hayashi, Ryota ; Takei, Shingo ; Ansai, Osamu ; Takatsuka, Sumiko ; Takenouchi, Tatsuya ; Saito, Kyota ; Suda, Kazuaki ; Yoshihara, Kosuke ; Nagai, Takahiro ; Okuda, Shujiro ; Fukumoto, Takaya ; Ansai, Shin‐ichi ; Nakamura, Anna ; Katsuumi, Koji ; Ariizumi, Takashi ; Ogose, Akira ; Kawashima, Hiroyuki ; Abe, Riichiro</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2553-a9e7b4c2096472476bea8ddad76be3cb19e7d5d96ef2a3bce7a19529e75a37b73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Adult</topic><topic>Antigens, CD34 - analysis</topic><topic>Antigens, CD34 - metabolism</topic><topic>CD34</topic><topic>CD34 antigen</topic><topic>Collagen</topic><topic>Female</topic><topic>Humans</topic><topic>hybrid schwannoma/neurofibroma</topic><topic>LZTR1</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Molecular modelling</topic><topic>Mutation</topic><topic>Neurilemmoma - diagnosis</topic><topic>Neurilemmoma - pathology</topic><topic>Neurofibroma - diagnosis</topic><topic>Neurofibroma - metabolism</topic><topic>Neurofibroma - pathology</topic><topic>Neurofibromatoses</topic><topic>Schwann cells</topic><topic>schwannomatosis</topic><topic>Skin Neoplasms - diagnosis</topic><topic>Skin Neoplasms - metabolism</topic><topic>Skin Neoplasms - pathology</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Katsumi, Tatsuya</creatorcontrib><creatorcontrib>Hayashi, Ryota</creatorcontrib><creatorcontrib>Takei, Shingo</creatorcontrib><creatorcontrib>Ansai, Osamu</creatorcontrib><creatorcontrib>Takatsuka, Sumiko</creatorcontrib><creatorcontrib>Takenouchi, Tatsuya</creatorcontrib><creatorcontrib>Saito, Kyota</creatorcontrib><creatorcontrib>Suda, Kazuaki</creatorcontrib><creatorcontrib>Yoshihara, Kosuke</creatorcontrib><creatorcontrib>Nagai, Takahiro</creatorcontrib><creatorcontrib>Okuda, Shujiro</creatorcontrib><creatorcontrib>Fukumoto, Takaya</creatorcontrib><creatorcontrib>Ansai, Shin‐ichi</creatorcontrib><creatorcontrib>Nakamura, Anna</creatorcontrib><creatorcontrib>Katsuumi, Koji</creatorcontrib><creatorcontrib>Ariizumi, Takashi</creatorcontrib><creatorcontrib>Ogose, Akira</creatorcontrib><creatorcontrib>Kawashima, Hiroyuki</creatorcontrib><creatorcontrib>Abe, Riichiro</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of dermatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Katsumi, Tatsuya</au><au>Hayashi, Ryota</au><au>Takei, Shingo</au><au>Ansai, Osamu</au><au>Takatsuka, Sumiko</au><au>Takenouchi, Tatsuya</au><au>Saito, Kyota</au><au>Suda, Kazuaki</au><au>Yoshihara, Kosuke</au><au>Nagai, Takahiro</au><au>Okuda, Shujiro</au><au>Fukumoto, Takaya</au><au>Ansai, Shin‐ichi</au><au>Nakamura, Anna</au><au>Katsuumi, Koji</au><au>Ariizumi, Takashi</au><au>Ogose, Akira</au><au>Kawashima, Hiroyuki</au><au>Abe, Riichiro</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Reevaluating hybrid neurofibroma/schwannoma: Predominance of schwannoma features despite CD34 positivity and initial neurofibroma diagnosis</atitle><jtitle>Journal of dermatology</jtitle><addtitle>J Dermatol</addtitle><date>2024-11</date><risdate>2024</risdate><volume>51</volume><issue>11</issue><spage>1461</spage><epage>1469</epage><pages>1461-1469</pages><issn>0385-2407</issn><issn>1346-8138</issn><eissn>1346-8138</eissn><abstract>Schwannomas consist of both high‐cellularity regions (Antoni A area) and hypocellular regions (Antoni B area) in histopathological findings. Neurofibromas characteristically consist of CD34 positive spindle cells with thin, wavy, nuclei and wavy collagen bands. Previous reports have described segments of schwannomas with neurofibroma features as hybrid tumors, although hybrid tumors were diagnosed based on partial CD34 positivity in many previous reports. On the other hand, the Antoni B area of some schwannomas was reported to be positive for CD34. Therefore, the definition of a hybrid tumor has not been clear. The objective of this study was to determine whether only CD34 positive findings in schwannomas could be used to define a hybrid tumor. In the analysis of our patient with schwannomatosis caused by a novel LZTR1 germline mutation, part of the tumor had CD34 positive hypocellular regions. These regions contained no thin, wavy, nuclei, indicating an Antoni B area. Laser microdissection was used to investigate the genetic background and differences in molecular mechanisms between CD34 positive and CD34 negative regions. All mutations identified in CD34 positive regions were also found in CD34 negative regions. Our data could not clear the genetic background of Antoni B which was CD34 positive area. We then reviewed the pathologies of 66 sporadic schwannomas. Histopathological examinations of all schwannomas revealed the absence of thin, wavy, nuclei and wavy collagen bands, and no hybrid tumors were found in any of the cases. Ten of 66 patients were randomly selected for CD34 immunostaining and positivity was found in all cases. Our data suggest that it is difficult to distinguish schwannomas by staining for CD34 alone, as Antoni B areas can also be positive for CD34. Therefore, CD34 staining alone should not be used to diagnose hybrid tumors in patients with schwannomas.</abstract><cop>England</cop><pub>Wiley Subscription Services, Inc</pub><pmid>39487562</pmid><doi>10.1111/1346-8138.17343</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0002-7582-8609</orcidid><orcidid>https://orcid.org/0000-0001-6998-531X</orcidid><orcidid>https://orcid.org/0000-0001-9944-2228</orcidid><orcidid>https://orcid.org/0000-0002-6818-944X</orcidid><orcidid>https://orcid.org/0000-0002-0373-5833</orcidid><orcidid>https://orcid.org/0000-0001-7036-7084</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0385-2407
ispartof Journal of dermatology, 2024-11, Vol.51 (11), p.1461-1469
issn 0385-2407
1346-8138
1346-8138
language eng
recordid cdi_proquest_miscellaneous_3123549077
source MEDLINE; Access via Wiley Online Library
subjects Adult
Antigens, CD34 - analysis
Antigens, CD34 - metabolism
CD34
CD34 antigen
Collagen
Female
Humans
hybrid schwannoma/neurofibroma
LZTR1
Male
Middle Aged
Molecular modelling
Mutation
Neurilemmoma - diagnosis
Neurilemmoma - pathology
Neurofibroma - diagnosis
Neurofibroma - metabolism
Neurofibroma - pathology
Neurofibromatoses
Schwann cells
schwannomatosis
Skin Neoplasms - diagnosis
Skin Neoplasms - metabolism
Skin Neoplasms - pathology
Tumors
title Reevaluating hybrid neurofibroma/schwannoma: Predominance of schwannoma features despite CD34 positivity and initial neurofibroma diagnosis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-16T15%3A35%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Reevaluating%20hybrid%20neurofibroma/schwannoma:%20Predominance%20of%20schwannoma%20features%20despite%20CD34%20positivity%20and%20initial%20neurofibroma%20diagnosis&rft.jtitle=Journal%20of%20dermatology&rft.au=Katsumi,%20Tatsuya&rft.date=2024-11&rft.volume=51&rft.issue=11&rft.spage=1461&rft.epage=1469&rft.pages=1461-1469&rft.issn=0385-2407&rft.eissn=1346-8138&rft_id=info:doi/10.1111/1346-8138.17343&rft_dat=%3Cproquest_cross%3E3123165988%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3123165988&rft_id=info:pmid/39487562&rfr_iscdi=true